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Objectives: The purpose of this study was to investigate the efficacy of a composite surgical mesh for delivery of
mesenchymal stem cells (MSCs) in tendon repair.
Methods: The MSC-loaded mesh composed of a piece of conventional surgical mesh and a layer of scaffold, which
supported MSC-embedded alginate gel. A 3-mm defect was surgically created at the Achilles tendon-gastrocnemius/
soleus junction in 30 rats. The tendon defects were repaired with either 1) MSC-loaded mesh; or 2) surgical mesh only;
or 3) routine surgical suture. Repaired tendons were harvested at days 6 and 14 for histology, which was scored on the
bases of collagen organization, vascularity and cellularity, and immunohistochemisty of types I and III collagen.
Results: In comparison with the other two repair types, at day 6, the MSC-loaded mesh significantly improved the
quality of the repaired tendons with dense and parallel collagen bundles, reduced vascularity and increased type I
collagen. At day 14, the MSC-loaded mesh repaired tendons had better collagen formation and organization.
Conclusion: The MSC-loaded mesh enhanced early tendon healing, particularly the quality of collagen bundles.
Application of the MSC-loaded mesh, as a new device and MSC delivery vehicle, may benefit to early functional
recovery of the ruptured tendon.
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Tendon injury is one of the most common musculoskel-
etal conditions. Surgical repair of the ruptured tendon is
the standard of care. The long-term outcomes of the
surgery, however, vary greatly. In general, the repair is
inefficient: tendon heals slowly (8–12 weeks) [1]. After
surgical repair, in most of the cases, the tendon heals
not by a regenerative process (intrinsic healing) but ra-
ther by the formation of scar tissue (extrinsic healing)
[2]. The inferior properties of the repairing tissue may
cause significant dysfunction and even disability [3,4].
Clinically, there is great demand to improve the surgical
techniques and efficiency of tendon repair.* Correspondence: lewschon@gmail.com
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unless otherwise stated.Tendon rupture can occur at the muscle-tendon junc-
tion, the bone-tendon junction and the middle portion
of the tendon. Each type of the tendon injury has differ-
ent healing processes [5] and presents unique challenges
to repair. Suture is routinely used for tendon repair to
provide the essential stability for healing [6], but muscle
is a poor retainer of suture. To overcome this difficulty,
surgical mesh has been used to patch the ruptured
muscle-tendon junction to enforce the repair with
broadly distributed tension in the muscle. Achilles ten-
don ruptures are relatively common, with an estimated
rate of 18 per 100,000 people [6]. Approximately, 12% of
Achilles tendon injuries are ruptures at the muscle-tendon
junction [7].
Tenocytes that reside in the tendon are fully differenti-
ated and therefore have little capability of regeneration
[8]. Mesenchymal stem cells (MSCs) from the stroma of
bone marrow and other tissues are multipotent and cap-
able of forming bone, cartilage and other connective
tissues [9,10]. Although the regulation and milestoneLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Schon et al. Journal of Translational Medicine 2014, 12:110 Page 2 of 9
http://www.translational-medicine.com/content/12/1/110markers of tenogenic differentiation are still undefined
[3], MSCs differentiating into tenocytes and forming ten-
don tissue have been demonstrated [11-14]. More im-
pressively, implanted alone or with other biomaterials,
MSCs formed tendon-like tissue in vivo [15]. Clinical
applications of MSCs may fundamentally change the
process of tendon repair. It has been found that the
MSC-differentiated tendocytes produce largely type I
collagen but not type III collagen [16], which is increased
in the early stage of scar-like tendon repair. Supplemen-
tation of MSCs to tendon repair has been largely bene-
ficial [17,18]. For example, MSC-loaded collagen gel
significantly reinforced the mechanical strengthen of
repaired patellar tendon [19,20].
MSCs have the potential to modulate the process of
tendon repair or regenerate neo-tendon with improved
tissue structure, collagen organization, and matrix com-
position and thus the clinical outcomes. This study was
designed to investigate the efficacy of MSC-loaded
surgical mesh in tendon healing at the Achilles tendon-
gastrocnemius/soleus junction in rats. The repaired
Achilles tendons were examined with histology and immu-
nohistochemistry of types I and III collagen for evaluation
of the quantity of tendon repair.
Materials and methods
Design of MSC-loaded surgical mesh
The MSC-loaded surgical mesh was an integrated bio-
logically active composite structure consisting of surgical
mesh, polymer scaffold and MSC embedded hydrogel.
The knitted surgical mesh was made of polypropylene
(PPM1 Retain Mesh; Lot # 10-001253-1015, Biomedical
Structures, Warwick, RI), which is commonly used in
surgery for tissue repair. The mesh formed a broad base
for other layers to rest on. During tendon repair, the
mesh was used to patch over the injury site and provided
the necessary mechanical strength to bridge the ruptured
tendon. In this study, the dimensions of the mesh were
17 mm x 7 mm.
The second component of the MSC-loaded mesh was
a layer of non-woven scaffold, 4 x 4 x 2 mm3, made of
polyglycolic acid (PGA, 60 mg/ml in density, Lot # 10-
001253A-1015, Biomedical Structures). The scaffold was
attached to the center of the surgical mesh with one
knot using a 4–0 monofilament suture. The purpose of
the PGA scaffold was to support and attach the hydrogel
component to the mesh (Figure 1A).
Preparation of the MSC embedded alginate hydrogel
For isolation of MSCs, human bone marrow samples
were collected during orthopaedic surgery performed
at MedStar Union Memorial Hospital, Baltimore, MD
(approved by the Institutional Review Board of MedStar
Health Research Institute). The bone marrow was dilutedat a 1:1 ratio with phosphate buffered saline (PBS) with 2%
fetal bovine serum (FBS) and then layered on top of the
Ficoll-Paque™ PLUS density gradient medium (STEMCELL
Technologies, Vancouver, Canada) in a 50-ml conical tube
and centrifuged for 30 minutes at 400x g. The mono-
nuclear cell layer at the plasma-Ficoll interface was re-
moved and the mononuclear cells were washed once with
PSB containing 2% FBS before being plated in tissue cul-
ture flasks at a density of 4,000 cells per cm2. The isolated
MSCs were cultured in MesenCult® MSC Basal Medium
supplemented with MesenCult® Mesenchymal Stem Cell
Stimulatory Supplements (STEMCELL Technologies) at
37°C in a humidified incubator with 5% CO2 in air. The ad-
herent MSCs were passaged at 60-80% confluence. At pas-
sage 2, 1x106 MSCs were resuspended in 50 μl culture
medium and then mixed with 50 μl 2% alginate. Of the al-
ginate mixture, 40 μl (containing 4x105 MSCs) was added
onto the PGA scaffold and alginate polymerization was
subsequently initiated with CaCl2 (100 mM). Finally, MSCs
were embedded within alginate gel, which was attached to
the surgical mesh via PGA scaffold.
Samples of the surgical mesh constructs were incubated
with SYTO®10 (Life Technologies, Grand Island, NY),
which is a highly membrane-permeable green fluorescent
nucleic acid stain for viable cells, for MSC density and dis-
tribution in the scaffold. Examined under a fluorescent
microscope, MSCs evenly distributed within alginate gel
(Figure 1B).
MSC-loaded mesh for tendon repair in rats
The MSC-loaded surgical mesh was used immediately in
a rat model of tendon repair. A total of 30 Sprague-
Dawley rats, male, body weight 250–300 g, were used
for this study (approved by the Institutional Animal Care
and Use Committee, MedStar Health Research Institute).
The rats were anesthetized by intraperitoneal injection
of Nembutal (pentobarbital, 0.05 mg/g). The right hind-
limbs of the rats were shaved and prepared for surgery.
A longitudinal midline incision was made on the lower
limb to expose the Achilles tendon. The tendon was
completely severed at the Achilles tendon-gastrocnemius/
soleus junction. The muscle was transected 3 mm proxim-
ally to create a defect between the tendon and muscle tis-
sue. According to the repair methods, rats were divided
into three study groups: 1) repair using the composite sur-
gical mesh loaded with MSCs (group M+ S); 2) repair
using the composite surgical mesh, without loading of
MSCs (group M); or repair using suture only (group Sut).
For animals receiving one of the two surgical mesh types,
the mesh was applied so as to cover the created muscle-
tendon defect. With the hydrogel/PGA scaffold filled in
the defect, the mesh on the top was sutured to the Achilles
tendon and the gastrocnemius/soleus muscle at either end
of the defect (Figure 1C). For animals receiving suture
Figure 1 Design and application of MSC-loaded surgical mesh. A: Composition of MSC-loading mesh. B: Distribution of MSCs in the PGA-based
scaffold. MSCs (green) were labeled with fluorescent dye SYTO®10. PGA fibers also showed green in auto-fluorescence (bar = 50 μm). C: The MSC-loaded
mesh was used to repair the 3-mm defect (between the dot lines) created at the junction of Achilles tendon and gastrocnemius/soleus. The portion of
scaffold/MSCs was inserted into the defect and surgical mesh was sutured to the surface of muscle and tendon (black arrowhead indicates a knot of
surgical suture used to tie the scaffold and surgical mesh together. The suture was melted after autoclave).
Schon et al. Journal of Translational Medicine 2014, 12:110 Page 3 of 9
http://www.translational-medicine.com/content/12/1/110repair, the Achilles tendon and muscle ends were loosely
approximated through a figure-of-eight stitch with three
knots; prior to tying the knots, an instrument 3 mm in
width was placed between the tendon and muscle ends
to preserve the 3-mm defect. After repaired the tendon,
the wound was closed with 4–0 monofilament suture in
a subcutaneous fashion. The operated limbs were not
immobilized. Rats were allowed to access food and water
ad lib.
In each group, 5 rats were euthanized at 6 and 14 days
after repair. Tissues around the tendon defect were dis-
sected en bloc and fixed with 10% buffered formalin.
After embedded in paraffin, tissue samples were sec-
tioned for histology and immunohistochemistry. Tissue
sections (5 μm) were collected at 10 intervals through-
out the width of the repair site in the longitudinal plane
and numbered for better comparisons among the three
groups.
Ten sections from each tendon sample were chosen at
random and stained with hematoxylin and eosin (H&E).
Picrosirius Red staining for collagen was also performed.
The histology of tendon repair were evaluated by three
scorers blinded to the repair methods used and scored
on the bases of collagen organization, vascularity and
cellularity according to a modified tendon histological
scoring system [21,22]. Dense/clearly defined/parallel
collagen bundles oriented tangentally, a sparse network of
small arteries oriented parallel to the collagen fibers in
thin/fibrous septa between the bundles, and an even/sparse
distribution of cells between collagen bundles are charac-
teristics of a normal tendon, which would have the lowest
score (see Table 1 for details). The scores from the ten
slides of each tendon were averaged.Immunohistochemistry for types I and III collagen
was performed on the sections of repaired tendons that
were collected at days 6 and 14 after surgery in all
three study groups. After antigen retrieval (citric acid/
EDTA buffer, pH 6), tissue sections were blocked with
serum and hydrogen peroxide, before incubated with a
mouse antibody of type III collagen (1:100 dilution,
Sigma-Aldrich Co, St. Louis, MO) or goat antibody of
type I collagen (1:100 dilution, Santa Cruz Biotechnology,
Dallas, TX) overnight. Types I or III collagen was de-
tected with either rabbit anti-goat or rabbit anti-mouse
secondary antibody conjugated with horse radish perox-
idase and substrate 3, 3’-diaminobenzidine (DAB) was
used for colorimetric detection. Negative controls were
performed by replacing primary antibody with normal
mouse IgG or normal goat serum. Immunohistochemis-
try for each group was performed in triplicate. Immu-
nohistochemical staining for type I or III collagen was
carried out at the same time to reduce variables might
be introduced during the procedure. All the tissue sec-
tions were imaged under the same microscope with the
same settings in the same day. On each image, in a
computer defined area, the staining area (predefined
pixel units) and intensity (average grayscale) were mea-
sured using ImageJ (NIH).
Statistical analyses
Data were expressed as mean ± standard deviation. The
overall histological scores of tendon healing and scores
of sub-categories at days 6 and 14 were analyzed across
the three study groups using two-way ANOVA, followed
with Tukey’s post hoc analysis. P < 0.05 was set as statisti-
cally significant.
Table 1 Histological score of tendon repair
Score Collagen Angiogenesis Cellularity
0 dense, clearly defined parallel collagen
bundles oriented tangentally
a sparse network of small arteries oriented parallel
to the collagen fibers in thin, fibrous septa between
the bundles
fairly even, sparse distribution of cells with
thin wavy nuclei located between collagen
bundles
1 less than 25% of collagen bundles have a
diffuse structure with blurring of individual
bundles
less than 25% irregular vascularization: increased
capillaries
less than 25% abnormal increased cellularity
with rounded nuclei oriented in rows
2 less than 50% of collagen bundles have a
diffuse structure with blurring of individual
bundles
less than 50% irregular vascularization: increased
capillaries; groups of thick-walled vessels distributed
unevenly in the hypercellular tendon
less than 50% abnormal increased cellularity
with rounded nuclei oriented in rows
3 more than 50% of collagen bundles have a
diffuse structure with blurring of individual
bundles
more than 50% irregular vascularization: increased
capillaries; groups of thick-walled vessels distributed
unevenly in the hypercellular tendon; proliferating
vessels are nodular and may be perpendicular to
the collagen bundles
more than 50% abnormal increased
cellularity with rounded nuclei oriented
in rows
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III collagen among the three groups at different time-
points were analyzed. In addition, type III collagen: type
I collagen ratio in staining area and intensity of the same
group at the same time point was calculated and com-
pared among M + S, M and Sut groups at days 6 and 14.
Results
All rats survived from the surgery and through the follow-
up. No infection was observed at the surgical site. At the
time of tissue collection, tendon defect was repaired grossly
in all three study groups.
At day 6, histology showed that fibroblastic cells filled
in the tendon defects in all three groups. Although cell
density was high in both M and M + S groups, there was
no inflammatory response around PGA fibers. Com-
pared with M and Sut groups, there was more matrix
deposition in M + S group (Figure 2) and the matrix ap-
peared in an organized pattern that run in parallel along
the tendon (insert). The modified tendon repair score of
M + S group was significantly improved over the M and
Sut groups (p < 0.05; Figure 3A). When the scores were
further analyzed at subcategories, it appeared that re-
duced vascularity in M + S group contributed most to
the overall quality of the repaired tendon in M + S group
(Figure 3B).
By day 14, there were significant reduction of cellular-
ity and increased deposition of extracellular matrix in
the repaired tendon in all three groups (Figure 2). Com-
pared with M and M + S groups, cells in Sut group were
uniformly fibroblastic-like but deposited much less
matrix. While matrix and cells in M group were in a
chaotic or random pattern, much of the matrix and cells
in M + S group aligned in accordance with the orienta-
tion of the tendon. Histomorphometrically, the modified
tendon repair score of M + S group was improved over
both M and Sut groups at day 14, but this was not statis-
tically significant (Figure 3A). It was noticed that, underthe subcategory of collagen, M + S group was signifi-
cantly improved at day 14, compared with M and Sut
groups (p < 0.05; Figure 3C).
Immunohistochemistry demonstrated similar distribu-
tion patterns of types I and III collagen among the three
groups (Figure 4). At the same time point, type I colla-
gen staining area and intensity were not statistically dif-
ferent among the three groups in (Figure 5A and B).
The area of type I collagen staining increased from day 6
to day 14 in the M + S groups (p < 0.05), but this was
not in M and Sut groups.
Neither the area nor the average intensity of Type III
collagen was significantly different among the three
groups at both days 6 and 14 (Figure 5C and D).
The staining area ratio of type III collagen over type I
collagen in the M + S group was the highest, but it was
only statistically different between M + S and Sut groups
(Figure 5E). There were interesting trends of the area ra-
tio of type III collagen vs. type I collagen, although they
were not statistically significant. The ratio was reduced
from day 6 to day 14 in the M + S group (p = 0.06) and
M group, but increased in the Sut group.
The intensity ratio of type III collagen over type I col-
lagen showed not statistically different among M + S, M
and Sut groups at both day 6 and day 14 (Figure 5F).
Discussion
Surgical mesh is commonly used for repairing ruptures
at the muscle-tendon junction. In the current study, the
composite mesh was designed to not only bridge the de-
fect between Achilles tendon and the gastrocnemius/
soleus muscle but also carry MSCs to the site of tissue re-
pair. The MSC-loaded mesh consisted of multiple com-
ponents. All the materials making up the composite
mesh are commonly used in the surgery and biomedical
research [23,24]. The design of the composite mesh
emphasized its practicability during a surgical proced-
ure and versatility to varied tendon pathology and other
Figure 2 Histology of repaired tendons. At day 6, there was more extracellular matrix deposited in group M + S than in group M. Furthermore,
the matrix appeared more organized and parallel with the long axis of the tendon. By day 14, there were more fibroblastic cells and increased
matrix deposition in all three groups. The orientations of nuclei indicated that, in areas, cells in group M + S arranged in line with the long axis of
the tendon and that was not seen in group M. Matrix area and staining density in group Sut were much less than groups M + S and M (H&E
staining, inserts are Picrosirius Red staining; bar = 50 μm).
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be tailored to any size and shape to adapt the gap of
tendon rupture. The surgical mesh and scaffold were
stitched together with surgical sutures. This gives sur-
geons another layer of flexibility to arrange and secure
the scaffold to the mesh as needed on an individual
basis. The conventional surgical mesh restored the
mechanical continuity of the ruptured tendon and
might provide a physical environment that stimulates
tenogenesis of MSCs [25-27]. The scaffold was made of
PGA, which is biodegradable and has been used for
tendon repair [8]. In this MSC-loaded mesh, a layer of
scaffold ensured uniform and 3-dimensional MSC dis-
tribution, which was confirmed by staining MSCs in
the composite mesh. While injection of MSCs to the
injury site of the tendon is convenient to apply [17,28],
it is the advantage of the MSC-loaded mesh being able
to distribute MSCs evenly throughout the tendon defect.
This could be particularly important when MSCs are
used to repair large tendons/ligaments, such as Achilles
tendon and patellar ligament. Alginate gel in this com-
posite mesh provided MSCs a 3-dimensional environ-
ment. It has been found that MSCs in 3-dimensional
culture increase the expression of scleraxis, a marker
gene of tenogenic [26]. Alginate solution polymerizes
quickly by adding calcium. This offers the convenience to
incorporate MSCs to the composite mesh in a setting of
operation room.When MSCs were delivered to the defects between
Achilles tendon and gastrocnemius/soleus with MSC-
loaded mesh, tendon repair was improved at days 6 and
14 as indicated by the histological scores. However, it
was only at day 6, this improvement was statistically sig-
nificant. The effect of MSCs on the early stage of tendon
healing was also shown in an animal study of Achilles
rupture, where MSC injections increased the mechan-
ical strength of the repaired tendons at an early stage
(1–2 weeks) of tissue healing but not at the late stage
(after 3 weeks) [28]. At day 6, the improvement of tendon
repair in M + S group was supported with dense, parallel
collagen bundles and increased extracellular matrix, but
reduced vascularity was the main contributing factor. In
terms of the exact role of MSCs played in the process of
tendon repair in M + S group, however, it remains for fu-
ture investigation. MSCs are regenerative and there are
MSCs in tendon [29]. In a variety of tendon/ligament re-
pair models, applications of MSCs improve the healing
and mechanical property of the tendon [17-19]. It is
highly possible that, in the current study, locally delivered
MSCs went tenogenic differentiation and participated in
regeneration of neo-tendon. Unlike MSC osteogenesis,
chondrogenesis and adipogenesis that can be induced
with standardized protocols, the condition of MSC teno-
genic differentiation is still under development. It has
been found, however, that tendon itself promotes teno-
genic differentiation of MSCs [30,31]. In the current
Figure 4 Immunohistochemistry of types I and III collagen. In general, type I collagen was stained in larger fibers, while type III collagen was
detected on finer fibers in the repaired tendons. The distribution of types I and III collagen was very similar among the groups, except of
noticeable weak staining of type III collagen in the M group at day 6 (bar = 50 μm).
Figure 3 Quantification of tendon healing. A: The overall scores of the repaired tendons in three study groups. At day 6, tendon repair was
significantly improved in group M + S. B: The angiogenesis scores of the repaired tendons. At day 6, angiogenesis in group M + S was
significantly less than groups M and Sut. C: The collagen scores of the repaired tendons. The scores of collagen bundles in group M + S showed
significant improvement at day 14. D: No differences were found among groups in cellularity score (*p < 0.05; **p < 0.001).
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Figure 5 Quantification of immunohistochemistry of types I and III collagen in tendon repair. The staining of types I and III collagen was
quantified in 1) staining area (A and C) and 2) staining intensity (B and D). In M + S group, the area of type I collagen was significantly increased
from day 6 to day 14. The staining area of type III collagen was indifferent among the three groups. The area ratio of type III collagen over type I
collagen in M + S group was greater than in the Sut group at day 6 (E). No differences were detected in average intensity of types I and III
collagen, individually and the ratio (F), among the three groups.
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may present MSCs an optimal environment for tenogen-
esis. In addition, these MSCs might secrete a variety of
cytokines and growth factors that suppress the local
immune reaction, inhibit fibrosis (scar formation) and
stimulate tissue-intrinsic reparative or stem cells for
regeneration [10].
It is interesting to note that the cellularity was not
a contributing factor distinguished the M + S group
from others at day 6. This suggests that, at least, theimplantation of MSC-loaded mesh did not induce signifi-
cant inflammatory response locally. It is believed that in-
flammation causes scar formation and inevitably affect
the function of the repaired tendon [32].
The composition and organization of collagen in the
repairing tissue greatly influence tendon strength. In nat-
ural tendon healing, there are structural and functional
deficiencies that lead to inferior mechanical strength to
healthy tendon. In fact, the repaired tendon does not
achieve the normal failure force mechanically in years
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with significantly more collagen formation and much
better organized collagen bundles than the mesh only. It
suggests MSC implantation has the potential to improve
the mechanical strength of repaired tendon. This is in
line with other studies that applied MSCs to tendon re-
pair. In most of the studies, an improved mechanical
property of the repaired tendon stands out after ap-
plications of MSCs [20,28]. It is noteworthy that post-
transcriptional remodeling of collagen fibrils by matrix
metalloproteinases also contributes to the improved mech-
anical property of the MSC-mediated tendon repair [26].
Types I collagen is predominant in the extracellular
matrix of normal tendon. M + S group was the only one
that showed a significantly increased area of deposition
of type I collagen from day 6 to day 14. There is poten-
tial that the increased type I collagen in the matrix may
improve the strength of the repaired tendon in the M+ S
group. During tendon repair, type III collagen is increased
initially and persistent in scaring tissue [34,35]. In the
present study, type III collagen was indifference among
the three groups in either staining area or intensity. When
the ratio of type III collagen over type I collagen was con-
sidered, the staining area ratio in the M+ S group was sig-
nificantly greater than in the Sut group. The addition of
MSCs seemed to interfere with the process of tendon
healing and changed the composition of extracellular
matrix. However, the staining area ratio was gradually
decreased over the time in both M + S and M groups,
but increased in Sut group. Although these trends were
not statistically significant in the current study, different
repairing materials (i.e. surgical mesh vs. suture) and the
consequently mechanical environment might influence
the proportion of types III and I collagen in the repaired
tendons [26].
The initial inflammatory, proliferative phases of ten-
don repair involve in coordinated and complex molecu-
lar and cellular events, but last for a relatively short
period [1]. MSCs implanted into the ruptured tendons
most likely interfere with the biology of early tendon
repair. This study was primarily focused on the early
events after repairing tendon defects with MSC-loaded
surgical mesh. The limitations of this study include the
repaired tendons were not assessed with biomechanical
properties and the animals were followed up for only
a short period of time. Immunohistochemistry provides
useful information about the distribution patterns and
localization of types I and III collagen. However, it is not
an ideal method for quantification of types I and III col-
lagen in the repaired tendons.
Conclusion
In summary, a surgical mesh was modified with polymer
scaffold and hydrogel for transplantation of MSCs fortendon repair. The implantation of MSC-loaded mesh
was able to deliver MSCs locally and enhanced early ten-
don healing. Although the density of delivered MSCs
and the functional recovery of the repaired tendons are
to be evaluated in future studies, this study demon-
strated that MSC application influences the process of
tendon repair fundamentally [36]. The results are signifi-
cant for the care and surgery of tendon ruptures, as
gaining strength early will benefit to the functional re-
covery of repaired tendons.
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